Medicare Enrolled

Dr. Benito Marranzini, M.D.

Endocrinology · El Paso, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1516 LOMALAND DR., El Paso, TX 79935
9155932600
In practice since 2005 (20 years)
NPI: 1083617328 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Marranzini from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Marranzini? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Marranzini

Dr. Benito Marranzini is an endocrinology in El Paso, TX, with 20 years in practice. Based on federal Medicare data, Dr. Marranzini performed 798 Medicare services across 413 unique beneficiaries.

Between the years covered by Open Payments, Dr. Marranzini received a total of $28,813 from 67 pharmaceutical and/or device companies across 1751 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Marranzini is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 48% volume in TX$ $28,813 industry payments

Medicare Practice Summary

Medicare Utilization ↗
798
Medicare services
Top 48% in TX for endocrinology
413
Unique beneficiaries
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~40 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)603$84$263
Office visit, established patient, complex (40-54 min)116$121$346
New patient office visit, complex (60-74 min)29$150$496
Office visit, established patient (20-29 min)20$56$170
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report17$26$90
Hemoglobin A1c test (diabetes monitoring)13$9$40
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$28,813
Total received (2018-2024)
Avg $4,116/year across 7 years
Top 18% in TX for endocrinology
67
Companies
1,751
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$28,813 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,330
2023
$4,049
2022
$5,126
2021
$3,942
2020
$2,884
2019
$3,723
2018
$3,758

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$3,523
Novo Nordisk Inc
$3,423
Lilly USA, LLC
$2,005
Abbott Laboratories
$1,520
SANOFI-AVENTIS U.S. LLC
$1,501
AstraZeneca Pharmaceuticals LP
$1,410
Dexcom, Inc.
$1,372
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,287
Corcept Therapeutics
$982
Insulet Corporation
$932
RECORDATI_RARE_DISEASES_INC.
$931
Radius Health, Inc.
$789
Janssen Pharmaceuticals, Inc
$687
Bayer Healthcare Pharmaceuticals Inc.
$660
Amarin Pharma Inc.
$591
ABBVIE INC.
$512
Medtronic, Inc.
$430
Bayer HealthCare Pharmaceuticals Inc.
$408
Antares Pharma, Inc.
$383
Novartis Pharmaceuticals Corporation
$367
Tandem Diabetes Care, Inc.
$333
Regeneron Healthcare Solutions, Inc.
$332
Horizon Therapeutics plc
$315
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$307
Merck Sharp & Dohme Corporation
$296
AbbVie Inc.
$284
EUSA Pharma (US) LLC
$252
Biohaven Pharmaceuticals, Inc.
$244
DEXCOM, INC.
$237
Xeris Pharmaceuticals, Inc.
$204
Mannkind Corporation
$185
Medtronic MiniMed, Inc.
$174
AbbVie, Inc.
$163
PFIZER INC.
$135
Esperion Therapeutics, Inc.
$130
Biohaven Pharmaceutical Holding Company Ltd.
$125
Ultragenyx Pharmaceutical Inc.
$110
Inspire Medical Systems, Inc.
$109
Kowa Pharmaceuticals America, Inc.
$101
Alexion Pharmaceuticals, Inc.
$90
Vifor Pharma, Inc.
$87
EISAI INC.
$79
Kyowa Kirin, Inc.
$72
ARBOR PHARMACEUTICALS, INC.
$71
Takeda Pharmaceuticals U.S.A., Inc.
$68
Ascendis Pharma Inc
$68
BETA BIONICS, INC.
$66
Amryt Pharma Holdings Ltd
$54
Merck Sharp & Dohme LLC
$47
Madrigal Pharmaceuticals
$41
Allergan Inc.
$34
Supernus Pharmaceuticals, Inc.
$29
IBSA Pharma Inc.
$29
Ipsen Biopharmaceuticals, Inc
$27
Becton, Dickinson and Company
$26
OPKO Pharmaceuticals, LLC
$23
GlaxoSmithKline, LLC.
$20
Astellas Pharma US Inc
$19
Allergan, Inc.
$18
Ironwood Pharmaceuticals, Inc
$16
Shire North American Group Inc
$14
Avion Pharmaceuticals
$14
Strongbridge US INC.
$13
Nalpropion Pharmaceuticals LLC
$12
Eisai Inc.
$12
Aegerion Pharmaceuticals, Inc.
$11
CeQur Corporation
$6
Top 3 companies account for 31.1% of total payments
Associated products mentioned in payments ›
AFREZZA · Aimovig · Amitiza · Androgel · BAQSIMI · BASAGLAR · BD Nano · BELSOMRA · BYSTOLIC · Balcoltra · Belviq · CHANTIX · COMIRNATY · CONTRAVE · CeQur Simplicity · Corlanor · Crysvita · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · Dexcom CGM · Dexcom G6 Transmitter · Dexilant · ENTRESTO · EVENITY · EVKEEZA · Edarbi · Edarbyclor · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GARDASIL · GLYXAMBI · GUARDIAN SENSOR (3) · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · Horizant · ICD Leads · INCRELEX · INPEN SMART INSULIN DELIVERY SYSTEM · INSPIRE · INTELLIS ADAPTIVESTIM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LIVALO · LOKELMA · Linzess · Livalo · MACRILEN · MINIMED 770G · MINIMED 780G · MOUNJARO · MYALEPT · MYCAPSSA · Minimed 670G System · Minimed 770G System · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NURTEC ODT · OTREXUP · Omnipod · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR 13 · Prolia · QULIPTA · Quadra Assura CRT Defibrillator · RECORLEV · RESMETIROM · RYBELSUS · Rayaldee · Repatha · Rybelsus · SHINGRIX · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · SYNTHROID · Saxenda · Sogroya · Sylvant · Synthroid · TEFLARO · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Trintellix · Tymlos · UBRELVY · Vascepa · Veltassa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $3,611 per 100 Medicare services performed
Looking for a endocrinology in El Paso?
Compare endocrinologys in the El Paso area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
14
Per 100K population
1.6
County median income
$58,859
Nearest hospital
UNIVERSITY MEDICAL CENTER OF EL PASO
5.6 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Marranzini is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 18%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Marranzini experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Marranzini performed 603 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Marranzini receive payments from pharmaceutical companies?
Yes. Dr. Marranzini received a total of $28,813 from 67 companies across 1,751 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Marranzini's costs compare to other endocrinologys in El Paso?
Dr. Marranzini's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Marranzini) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →